| Dafer W Al-haddadin, MD | |
|
155 Borthwick Ave Ste 202, Portsmouth, NH 03801-7156 | |
| (603) 434-8733 | |
| (603) 433-8834 |
| Full Name | Dafer W Al-haddadin |
|---|---|
| Gender | Male |
| Speciality | Infectious Disease |
| Experience | 39 Years |
| Location | 155 Borthwick Ave Ste 202, Portsmouth, New Hampshire |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1932192945 | NPI | - | NPPES |
| P00467411 | Other | RAILROAD MEDICARE | |
| 200132160A | Medicaid | OK | |
| 200546850A | Medicaid | KS | |
| 208360206 | Medicaid | MO | |
| 221420 | Other | BLUES | |
| 200984520 | Medicaid | IN |
| Facility Name | Location | Facility Type |
|---|---|---|
| Portsmouth Regional Hospital | Portsmouth, NH | Hospital |
| Frisbie Memorial Hospital | Rochester, NH | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Appledore Medical Group Inc | 5698666154 | 89 |
News Archive
Univar Inc., a leading global chemical distributor, announced today that it has entered into an agreement with Swati Spentose Pvt. Ltd. to become its exclusive distributor of Lidocaine products, including Lidocaine Base and Lidocaine HCl in the United States.
Shire plc, the global specialty biopharmaceutical company, announced the US Food and Drug Administration (FDA) approval of Daytrana® (methylphenidate transdermal system) for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in adolescents aged 13 to 17 years. Daytrana, the first and only transdermal ADHD patch, is already an FDA-approved ADHD treatment for children 6 to 12 years. Daytrana is indicated as an integral part of a total treatment program for ADHD that may include other measures (psychological, educational, and social).
Following 27 years of research, Australian wild foods are now scientifically recognized as the world's most nutritious plant foods. Their food quality sustained the world's longest living culture - the Australian Aborigines - for over 60,000 years, and in better health than we have today.
Gene therapy developed at St. Jude Children's Research Hospital, University College London and the Royal Free Hospital has transformed life for men with a severe form of hemophilia B by providing a safe, reliable source of the blood clotting protein Factor IX that has allowed some to adopt a more active lifestyle, researchers reported.
› Verified 7 days ago
| Entity Name | Appledore Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1720077167 PECOS PAC ID: 5698666154 Enrollment ID: O20040601000165 |
News Archive
Univar Inc., a leading global chemical distributor, announced today that it has entered into an agreement with Swati Spentose Pvt. Ltd. to become its exclusive distributor of Lidocaine products, including Lidocaine Base and Lidocaine HCl in the United States.
Shire plc, the global specialty biopharmaceutical company, announced the US Food and Drug Administration (FDA) approval of Daytrana® (methylphenidate transdermal system) for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in adolescents aged 13 to 17 years. Daytrana, the first and only transdermal ADHD patch, is already an FDA-approved ADHD treatment for children 6 to 12 years. Daytrana is indicated as an integral part of a total treatment program for ADHD that may include other measures (psychological, educational, and social).
Following 27 years of research, Australian wild foods are now scientifically recognized as the world's most nutritious plant foods. Their food quality sustained the world's longest living culture - the Australian Aborigines - for over 60,000 years, and in better health than we have today.
Gene therapy developed at St. Jude Children's Research Hospital, University College London and the Royal Free Hospital has transformed life for men with a severe form of hemophilia B by providing a safe, reliable source of the blood clotting protein Factor IX that has allowed some to adopt a more active lifestyle, researchers reported.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dafer W Al-haddadin, MD 155 Borthwick Ave Ste 202, Portsmouth, NH 03801-7156 Ph: (603) 434-8733 | Dafer W Al-haddadin, MD 155 Borthwick Ave Ste 202, Portsmouth, NH 03801-7156 Ph: (603) 434-8733 |
News Archive
Univar Inc., a leading global chemical distributor, announced today that it has entered into an agreement with Swati Spentose Pvt. Ltd. to become its exclusive distributor of Lidocaine products, including Lidocaine Base and Lidocaine HCl in the United States.
Shire plc, the global specialty biopharmaceutical company, announced the US Food and Drug Administration (FDA) approval of Daytrana® (methylphenidate transdermal system) for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in adolescents aged 13 to 17 years. Daytrana, the first and only transdermal ADHD patch, is already an FDA-approved ADHD treatment for children 6 to 12 years. Daytrana is indicated as an integral part of a total treatment program for ADHD that may include other measures (psychological, educational, and social).
Following 27 years of research, Australian wild foods are now scientifically recognized as the world's most nutritious plant foods. Their food quality sustained the world's longest living culture - the Australian Aborigines - for over 60,000 years, and in better health than we have today.
Gene therapy developed at St. Jude Children's Research Hospital, University College London and the Royal Free Hospital has transformed life for men with a severe form of hemophilia B by providing a safe, reliable source of the blood clotting protein Factor IX that has allowed some to adopt a more active lifestyle, researchers reported.
› Verified 7 days ago
Robert Millstein, MD Infectious Disease Medicare: Not Enrolled in Medicare Practice Location: 100 Campus Dr, Suite 12, Portsmouth, NH 03801 Phone: 603-422-8208 Fax: 603-422-8219 | |
Mr. Hanad Omar, M.D. Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 333 Borthwick Avenue, Portsmouth, NH 03801 Phone: 603-436-5110 | |
Thomas P Clairmont Jr., MD Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 330 Borthwick Ave, Suite 205, Portsmouth, NH 03801 Phone: 603-436-6115 Fax: 603-433-5567 | |
Daniel L Davies, DO Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 155 Borthwick Ave, Suite 202w, Portsmouth, NH 03801 Phone: 603-433-8434 Fax: 603-436-6608 | |
Brian Choi, M.D. Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 333 Borthwick Ave, Portsmouth, NH 03801 Phone: 215-442-5031 | |
Dr. Sucharit Suresh Joshi, M.D. Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 875 Greenland Rd, #c-10, Portsmouth, NH 03801 Phone: 603-436-3433 Fax: 603-427-5115 | |
Dr. Michael Casimir Danielski, M.D. Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 875 Greenland Rd, #c-10, Portsmouth, NH 03801 Phone: 603-436-3433 Fax: 603-427-5115 |